BACKGROUND: There is growing evidence suggesting that early adversity may be a marker for a distinct pathway to major depressive disorder (MDD). We examined associations between childhood adversity and a broad variety of clinical characteristics and response to pharmacotherapy in a large sample of patients with chronic forms of MDD. METHODS: Subjects included 808 patients with chronic forms of MDD (chronic MDD, double depression, or recurrent MDD with incomplete recovery between episodes and a total continuous duration of >2 years) who were enrolled in a 12-week open-label trial of algorithm-guided pharmacotherapy. Baseline assessments included a semi-structured diagnostic interview, and clinician- and self-rated measures of depressive symptoms, social functioning, depressotypic cognitions, and personality traits, and childhood adversity. Patients were re-evaluated every 2 weeks. RESULTS: A longer duration of illness; earlier onset; greater number of episodes, symptom severity, self-rated functional impairment, suicidality, and comorbid anxiety disorder; and higher levels of dysfunctional attitudes and self-criticism were each associated with multiple forms of childhood adversity. A history of maternal overcontrol, paternal abuse, paternal indifference, sexual abuse, and an index of clinically significant abuse each predicted a lower probability of remission. Among patients completing the 12-week trial, 32% with a history of clinically significant abuse, compared to 44% without such a history, achieved remission. CONCLUSIONS: These findings indicate that a history of childhood adversity is associated with an especially chronic form of MDD that is less responsive to antidepressant pharmacotherapy. (c) 2009 Wiley-Liss, Inc.
BACKGROUND: There is growing evidence suggesting that early adversity may be a marker for a distinct pathway to major depressive disorder (MDD). We examined associations between childhood adversity and a broad variety of clinical characteristics and response to pharmacotherapy in a large sample of patients with chronic forms of MDD. METHODS: Subjects included 808 patients with chronic forms of MDD (chronic MDD, double depression, or recurrent MDD with incomplete recovery between episodes and a total continuous duration of >2 years) who were enrolled in a 12-week open-label trial of algorithm-guided pharmacotherapy. Baseline assessments included a semi-structured diagnostic interview, and clinician- and self-rated measures of depressive symptoms, social functioning, depressotypic cognitions, and personality traits, and childhood adversity. Patients were re-evaluated every 2 weeks. RESULTS: A longer duration of illness; earlier onset; greater number of episodes, symptom severity, self-rated functional impairment, suicidality, and comorbid anxiety disorder; and higher levels of dysfunctional attitudes and self-criticism were each associated with multiple forms of childhood adversity. A history of maternal overcontrol, paternal abuse, paternal indifference, sexual abuse, and an index of clinically significant abuse each predicted a lower probability of remission. Among patients completing the 12-week trial, 32% with a history of clinically significant abuse, compared to 44% without such a history, achieved remission. CONCLUSIONS: These findings indicate that a history of childhood adversity is associated with an especially chronic form of MDD that is less responsive to antidepressant pharmacotherapy. (c) 2009 Wiley-Liss, Inc.
Authors: Elliot C Nelson; Andrew C Heath; Pamela A F Madden; M Lynne Cooper; Stephen H Dinwiddie; Kathleen K Bucholz; Anne Glowinski; Tara McLaughlin; Michael P Dunne; Dixie J Statham; Nicholas G Martin Journal: Arch Gen Psychiatry Date: 2002-02
Authors: Meena Vythilingam; Christine Heim; Jeffrey Newport; Andrew H Miller; Eric Anderson; Richard Bronen; Marijn Brummer; Lawrence Staib; Eric Vermetten; Dennis S Charney; Charles B Nemeroff; J Douglas Bremner Journal: Am J Psychiatry Date: 2002-12 Impact factor: 18.112
Authors: David P Bernstein; Judith A Stein; Michael D Newcomb; Edward Walker; David Pogge; Taruna Ahluvalia; John Stokes; Leonard Handelsman; Martha Medrano; David Desmond; William Zule Journal: Child Abuse Negl Date: 2003-02
Authors: Charles B Nemeroff; Christine M Heim; Michael E Thase; Daniel N Klein; A John Rush; Alan F Schatzberg; Philip T Ninan; James P McCullough; Paul M Weiss; David L Dunner; Barbara O Rothbaum; Susan Kornstein; Gabor Keitner; Martin B Keller Journal: Proc Natl Acad Sci U S A Date: 2003-11-13 Impact factor: 11.205
Authors: Laura C Bruce; Richard G Heimberg; Carlos Blanco; Franklin R Schneier; Michael R Liebowitz Journal: Depress Anxiety Date: 2011-11-07 Impact factor: 6.505
Authors: Laura M Hack; Gabriel R Fries; Harris A Eyre; Chad A Bousman; Ajeet B Singh; Joao Quevedo; Vineeth P John; Bernhard T Baune; Boadie W Dunlop Journal: J Affect Disord Date: 2019-02-06 Impact factor: 4.839
Authors: Benjamin G Shapero; Shimrit K Black; Richard T Liu; Joshua Klugman; Rachel E Bender; Lyn Y Abramson; Lauren B Alloy Journal: J Clin Psychol Date: 2013-06-25
Authors: Paul R Duberstein; Erin A Ward; Linda H Chaudron; Hue He; Sheree L Toth; Wenjuan Wang; Kimberly A Van Orden; Stephanie A Gamble; Nancy L Talbot Journal: J Consult Clin Psychol Date: 2018-10
Authors: Maura Boldrini; Tanya H Butt; Adrienne N Santiago; Hadassah Tamir; Andrew J Dwork; Gorazd B Rosoklija; Victoria Arango; René Hen; J John Mann Journal: Int J Neuropsychopharmacol Date: 2014-06-27 Impact factor: 5.176
Authors: Bruce A Arnow; Dana Steidtmann; Christine Blasey; Rachel Manber; Michael J Constantino; Daniel N Klein; John C Markowitz; Barbara O Rothbaum; Michael E Thase; Aaron J Fisher; James H Kocsis Journal: J Consult Clin Psychol Date: 2013-01-21